Introduction

Hepatitis B virus (HBV) infection produces a remarkably broad spectrum of disease—from asymptomatic infection and self-limited acute hepatitis to fulminant hepatitis, chronic hepatitis, cirrhosis and hepatocellular carcinoma (HCC).

The most important principle in understanding HBV pathogenesis is:

Thus, the clinical outcome is determined by the complex interaction between:

• HBV replication

• Viral antigen expression

• Innate immunity

• HBV-specific adaptive immunity

• Age at infection

• Host genetics

• Viral genotype and mutations

• Duration and intensity of inflammation

• Development of fibrosis

• Viral DNA integration

• Metabolic and environmental cofactors

The immune response that successfully clears HBV can simultaneously produce hepatitis. Conversely, an ineffective immune response may permit viral persistence and chronic liver disease.

1. Overview of HBV Pathogenesis

The pathogenesis of HBV infection can be simplified into six major stages:

Exposure → hepatocyte infection → viral replication → host immune recognition → immune-mediated liver injury → clearance or persistence

The eventual outcome depends primarily on the effectiveness and timing of the host immune response.

Two broad outcomes

Strong, coordinated immune response

→ effective viral control→ hepatocyte injury→ acute hepatitis→ viral clearance→ anti-HBs development

Weak, ineffective or dysregulated immune response

→ persistent HBV replication/cccDNA persistence→ chronic infection→ chronic necroinflammation→ fibrosis→ cirrhosis→ increased HCC risk

2. Is HBV Directly Cytopathic?

The classic concept

HBV is considered a predominantly non-cytopathic virus.

HBV can replicate within hepatocytes without necessarily causing immediate cellular destruction.

Experimental observations demonstrated that hepatocytes can contain replicating HBV before significant inflammatory liver injury occurs.

The major determinant of liver injury is therefore the host immune response.

Important distinction

HBV therefore represents an excellent example of virus-host immunopathogenesis.

3. Hepatocyte Infection

HBV reaches the liver through the bloodstream and infects hepatocytes.

The major entry receptor is:

Sodium taurocholate cotransporting polypeptide (NTCP)

The large surface protein of HBV (L-HBsAg), particularly its pre-S1 domain, interacts with NTCP following initial attachment to hepatocyte surface molecules.

After entry:

HBV nucleocapsid → cytoplasm → nucleus → rcDNA → cccDNA

The cccDNA becomes a stable nuclear transcriptional template.

This is central to HBV persistence.

4. cccDNA: The Molecular Reservoir

Following infection, relaxed circular DNA (rcDNA) is transported into the nucleus and repaired into:

Covalently closed circular DNA — cccDNA

cccDNA exists as a viral minichromosome associated with host histones and other nuclear proteins.

It serves as the template for transcription of:

• pregenomic RNA

• precore RNA

• surface transcripts

• X mRNA

• other viral RNAs

Why cccDNA matters

cccDNA can persist in hepatocytes even when serum HBV DNA becomes undetectable.

Therefore:

HBV DNA suppression ≠ complete eradication of HBV

This explains:

• viral persistence

• reactivation

• difficulty achieving a sterilizing cure

• prolonged treatment requirements

5. Viral Antigens and Immune Recognition

HBV produces several important antigens.

HBV antigens can be presented to immune cells through major histocompatibility complex (MHC) pathways.

The quality of this antigen-specific immune response strongly influences the outcome.

6. Innate Immune Response

The innate immune system is the first line of host defense.

Important components include:

• Kupffer cells

• Natural killer (NK) cells

• NKT cells

• hepatocytes

• dendritic cells

• macrophages

• pattern-recognition receptors

• interferons

• inflammatory cytokines

• chemokines

However, HBV is often described as producing a relatively limited or delayed innate immune signature during early infection compared with many strongly inflammatory viruses.

This has sometimes been described as a “stealth-like” infection, although the exact mechanisms are complex and context dependent.

7. HBV Sensing by Pattern-Recognition Receptors

Potential HBV-sensing pathways include:

TLR pathways

Toll-like receptors can influence:

• interferon production

• inflammatory cytokines

• antiviral responses

RIG-I/MDA5 pathways

These cytoplasmic RNA-sensing systems can recognize viral RNA-associated signals and activate antiviral signaling.

cGAS-STING pathway

DNA-sensing pathways can potentially detect HBV-associated nucleic-acid signals and contribute to innate antiviral responses.

However, HBV has evolved multiple mechanisms that can modulate host antiviral signaling.

8. Interferons

Interferons are important antiviral mediators.

Type I interferons

• IFN-α

• IFN-β

Type III interferons

• IFN-λ family

These can activate antiviral genes and suppress HBV replication.

Importantly, antiviral cytokines can inhibit HBV replication without necessarily killing the infected hepatocyte.

This is known as:

Non-cytolytic viral suppression

This concept is extremely important in HBV pathogenesis.

9. Natural Killer Cells

NK cells are abundant in the liver.

They contribute to:

• early antiviral defense

• cytokine production

• infected-cell killing

• recruitment and activation of other immune cells

Important NK-derived mediators include:

• IFN-γ

• TNF-α

However, excessive NK-cell activity can contribute to liver injury.

Thus:

Antiviral activity and immunopathology can occur simultaneously.

10. Adaptive Immunity: The Central Determinant

Adaptive immunity is particularly important in determining whether HBV infection resolves or becomes chronic.

The major components are:

Cellular immunity

• CD8+ cytotoxic T lymphocytes

• CD4+ helper T cells

Humoral immunity

• B cells

• plasma cells

• anti-HBs antibodies

Among these, the HBV-specific T-cell response is particularly important for viral clearance.

11. CD8+ Cytotoxic T Lymphocytes

CD8+ T cells recognize HBV-derived peptides presented on:

MHC class I

on infected hepatocytes.

Activated HBV-specific CTLs can destroy infected hepatocytes through:

1. Perforin–granzyme pathway

CTL:

→ releases perforin→ creates membrane pores→ granzyme enters→ activates apoptosis

2. Fas–Fas ligand pathway

CTL:

→ Fas ligand expression→ Fas activation on target cell→ caspase activation→ apoptosis

These mechanisms contribute to hepatocyte destruction.

12. CTLs Also Suppress HBV Without Killing Cells

One of the most fascinating aspects of HBV immunopathogenesis is that CTLs can suppress HBV replication without necessarily destroying the hepatocyte.

Important cytokines include:

• IFN-γ

• TNF-α

These can inhibit viral replication through intracellular antiviral mechanisms.

Therefore:

CTLs have two major functions

Cytolytic

→ kill infected hepatocytes

Non-cytolytic

→ suppress HBV replication within infected and neighboring cells

This allows the immune system to reduce viral replication while limiting hepatocellular destruction.

13. CD4+ T Helper Cells

CD4+ T cells support both cellular and humoral immunity.

They contribute through:

• activation of CD8+ T cells

• cytokine production

• B-cell help

• antibody production

• maintenance of antiviral immune memory

A strong, broad and coordinated CD4+/CD8+ response is associated with effective control of HBV.

14. B Cells and Anti-HBs

B cells produce antibodies against HBV antigens.

The most important protective antibody is:

Anti-HBs

Anti-HBs can neutralize circulating HBV virions by binding surface antigen.

This prevents:

• hepatocyte attachment

• viral entry

• spread to new susceptible hepatocytes

Therefore:

Anti-HBs = major marker of protective humoral immunity

This principle forms the immunological basis of HBV vaccination.

15. Anti-HBc and Humoral Immunity

Anti-HBc develops during natural infection.

However:

Anti-HBc primarily indicates exposure to HBV.

This distinction becomes extremely important when interpreting HBV serology.

16. Why Does Acute Hepatitis Occur?

During acute HBV infection:

HBV replication

↓

HBV antigen presentation

↓

activation of HBV-specific T cells

↓

CTL recruitment to liver

↓

infected hepatocyte killing

↓

inflammatory cytokine release

↓

hepatocellular injury

↓

ALT/AST elevation

↓

clinical hepatitis

Thus, the appearance of hepatitis often reflects an effective immune response.

17. Acute HBV Infection: Immune Clearance

A strong immune response produces:

• broad CD8+ T-cell responses

• effective CD4+ T-cell help

• neutralizing antibody production

• suppression of HBV replication

• elimination of infected hepatocytes

Eventually:

HBsAg disappears

↓

anti-HBs appears

↓

HBV DNA becomes undetectable

↓

immune control is established

The majority of immunocompetent adults with acute HBV infection clear the infection.

18. Why Is Chronic Infection More Common in Infants?

The age at infection is one of the most important determinants of outcome.

Infection in adulthood

More likely:

strong immune response → acute hepatitis → clearance

Infection during infancy/perinatal period

More likely:

ineffective/tolerant immune response → persistence → chronic infection

This is why prevention of mother-to-child transmission is such a major component of HBV elimination strategies.

WHO identifies mother-to-child transmission around birth as a major contributor to the global chronic HBV burden.

19. Immune Tolerance and Immune Dysfunction

Persistent HBV infection is associated with inadequate or dysfunctional HBV-specific immunity.

Several mechanisms contribute.

Possible mechanisms include:

• weak HBV-specific T-cell responses

• functional T-cell exhaustion

• impaired CD4+ T-cell help

• altered antigen presentation

• high antigen burden

• immune-regulatory pathways

• regulatory T-cell activity

• persistent exposure to viral antigens

20. T-Cell Exhaustion

During chronic HBV infection, HBV-specific T cells may become functionally impaired.

Features can include:

• reduced proliferation

• reduced cytokine production

• impaired cytotoxic function

• altered metabolic function

• increased inhibitory receptor expression

Important inhibitory receptors studied in chronic HBV include:

• PD-1

• CTLA-4

• TIM-3

• LAG-3

Concept

Persistent antigen exposure

↓

continuous T-cell stimulation

↓

functional impairment

↓

reduced viral clearance

↓

persistent HBV infection

T-cell exhaustion is an important concept, although chronic HBV immunopathogenesis is considerably more complex than a single checkpoint pathway.

21. HBeAg and Immune Modulation

HBeAg is a secreted viral protein derived from the precore/core region.

It is not required for HBV replication itself.

However, HBeAg can influence host immune responses.

High HBeAg exposure, particularly during perinatal infection, has been associated with immune tolerance/modulation that favors viral persistence.

This helps explain why HBeAg-positive maternal infection is associated with a high risk of transmission and chronic infection in the newborn.

22. Chronic HBV Infection

When the host fails to eliminate HBV:

cccDNA persists

↓

ongoing viral transcription

↓

variable HBV replication

↓

persistent antigen exposure

↓

immune-mediated inflammation

↓

hepatocyte injury

↓

fibrosis

↓

cirrhosis ± HCC

Importantly, chronic HBV infection is not characterized by continuously maximal viral replication.

HBV replication and host immune activity can fluctuate over many years.

23. The Four Traditional Immunological Phases

Historically, chronic HBV infection has been divided into four broad phases.

Modern guidelines emphasize that chronic HBV is dynamic and that these categories should not be interpreted as perfectly fixed biological states.

24. HBeAg-Negative Chronic Hepatitis

A particularly important phenomenon is:

HBeAg-negative chronic hepatitis

This often results from viral mutations, particularly:

• precore mutations

• basal core promoter mutations

The virus may continue replicating despite the absence of HBeAg.

Therefore:

This is a major clinical and diagnostic pearl.

25. Mechanism of Chronic Hepatocellular Injury

Persistent infection can result in repeated cycles of:

immune recognition

→ hepatocyte injury

→ cell death

→ regeneration

→ inflammation

→ further immune recruitment

→ additional injury

Over years, this creates a chronic inflammatory environment.

26. Role of Kupffer Cells

Kupffer cells are resident macrophages of the liver.

During chronic HBV infection they can respond to:

• viral products

• hepatocyte injury

• cytokines

• chemokines

• damage-associated molecular patterns

They can produce inflammatory mediators including:

• TNF-α

• IL-1

• IL-6

• chemokines

• TGF-β-related profibrotic signals

Kupffer-cell activation therefore contributes to both inflammation and fibrosis.

27. Hepatic Stellate Cells and Fibrosis

The major effector cells responsible for hepatic fibrogenesis are:

Hepatic stellate cells

Persistent inflammation activates stellate cells.

Activated stellate cells transform into a myofibroblast-like phenotype.

They produce:

• collagen

• extracellular matrix

• fibrogenic proteins

Important mediators include:

TGF-β

and

PDGF

28. Progression to Cirrhosis

The sequence can be represented as:

Chronic HBV infection

↓

persistent necroinflammation

↓

stellate-cell activation

↓

extracellular matrix deposition

↓

portal/periportal fibrosis

↓

bridging fibrosis

↓

architectural distortion

↓

cirrhosis

Cirrhosis produces:

• portal hypertension

• hepatic insufficiency

• ascites

• variceal bleeding

• hepatic encephalopathy

• increased HCC risk

29. Why Can HBV Cause HCC Even Without Cirrhosis?

This is a crucial distinction between HBV and several other chronic liver diseases.

HBV can increase HCC risk through:

Indirect mechanisms

• chronic inflammation

• hepatocyte death

• compensatory regeneration

• oxidative stress

• fibrosis/cirrhosis

Direct viral mechanisms

• HBV DNA integration

• HBx activity

• altered cellular signaling

• genomic instability

• epigenetic changes

• effects of viral protein expression

• selected viral mutations

Therefore:

Current literature continues to support both inflammatory/fibrotic and direct viral mechanisms in HBV-associated hepatocarcinogenesis.

30. HBV DNA Integration

HBV DNA can integrate into the host hepatocyte genome.

Important point

Integration is:

NOT required for HBV replication.

Instead, integration contributes to long-term host-cell genomic alterations and oncogenesis.

Integrated HBV DNA may result in:

• insertional mutagenesis

• chromosomal rearrangements

• genomic instability

• altered host gene expression

• expression of viral proteins/fragments

HBV integration has been detected not only in HCC but also in non-tumorous liver tissue, indicating that integration can occur before malignant transformation.

31. HBx and Hepatocarcinogenesis

HBx is a multifunctional viral regulatory protein.

It influences:

• transcription

• signal transduction

• cell-cycle regulation

• apoptosis

• DNA repair

• oxidative stress

• epigenetic regulation

• viral transcription/replication

HBx can interfere with several host pathways involved in carcinogenesis.

Mechanisms described include effects on:

• NF-κB

• p53-related pathways

• PI3K/AKT

• MAPK signaling

• mitochondrial signaling

• epigenetic regulation

HBx therefore provides a major molecular bridge between HBV infection and HCC development.

32. Pre-S Mutants and HCC

Mutations/deletions involving the pre-S region can lead to abnormal accumulation of surface proteins within the endoplasmic reticulum.

This can produce:

• ER stress

• oxidative stress

• genomic instability

• altered signaling

• increased hepatocyte proliferation

Certain pre-S variants are therefore associated with increased risk of progressive liver disease and HCC.

33. Oxidative Stress

Chronic HBV infection can generate oxidative stress through:

• inflammatory cells

• mitochondrial dysfunction

• viral protein effects

• repeated hepatocyte injury

• regeneration

Reactive oxygen species can cause:

• lipid peroxidation

• DNA damage

• protein modification

• genomic instability

Accumulation of genetic damage contributes to carcinogenesis.

34. Chronic Regeneration and Cancer Risk

Repeated hepatocyte destruction stimulates compensatory regeneration.

The sequence becomes:

hepatocyte death

↓

regenerative proliferation

↓

DNA replication

↓

greater opportunity for mutations

↓

clonal expansion

↓

additional genetic/epigenetic alterations

↓

malignant transformation

This is one of the major indirect mechanisms through which chronic HBV infection promotes HCC.

35. HBV and Immune-Mediated Extrahepatic Disease

HBV is not exclusively a liver disease.

Circulating HBV antigens can participate in immune-complex formation.

These immune complexes may deposit in tissues and activate inflammatory pathways.

Important extrahepatic manifestations include:

• polyarteritis nodosa

• glomerulonephritis

• mixed cryoglobulinemia

• arthralgia

• serum sickness-like manifestations

• skin manifestations

36. Polyarteritis Nodosa

HBV-associated polyarteritis nodosa is a classic extrahepatic manifestation.

It is a necrotizing vasculitis affecting medium-sized arteries.

Possible manifestations include:

• fever

• myalgia

• abdominal pain

• hypertension

• renal ischemia

• neuropathy

• skin lesions

The pathogenesis is largely related to immune-complex deposition.

37. HBV-Associated Glomerulonephritis

HBV has been associated with several forms of glomerular disease, particularly:

• membranous nephropathy

• membranoproliferative glomerulonephritis

Mechanism:

HBV antigen

↓

immune-complex formation

↓

glomerular deposition

↓

complement activation

↓

glomerular injury

↓

proteinuria ± nephrotic syndrome

38. Factors Determining HBV Disease Outcome

The outcome of HBV infection is determined by a combination of viral and host factors.

Host factors

• Age at infection

• Sex

• HLA genotype

• Genetic background

• Immune competence

• Immunosuppression

• Pregnancy-related factors

• Metabolic disease

• Alcohol exposure

Viral factors

• HBV genotype

• Viral load

• HBeAg status

• Precore mutations

• Basal core promoter mutations

• Surface antigen mutations

• Pre-S mutations

• Duration of infection

• cccDNA burden

• Viral integration

Coinfections

• HDV

• HCV

• HIV

can modify disease progression.

39. HBV Viral Load and Pathogenesis

HBV DNA level is an important marker of viral replication and disease activity.

Generally:

higher HBV DNA

→ greater probability of ongoing viral replication

→ greater risk of chronic liver injury and long-term complications in appropriate clinical contexts.

However:

Interpretation requires integration with:

• ALT

• HBeAg

• age

• fibrosis stage

• liver inflammation

• clinical status

• other risk factors

This is why modern HBV management uses a multidimensional assessment rather than viral load alone.

40. HBV Genotype and Pathogenesis

HBV is classified into multiple genotypes.

Genotype can influence:

• natural history

• HBeAg seroconversion

• disease progression

• risk of cirrhosis

• HCC risk

• treatment response

However, genotype is only one component of disease risk and should not be interpreted independently of host and clinical factors.

41. HBV Mutations and Pathogenesis

Because HBV uses reverse transcription, replication is prone to genetic variation.

Important clinically relevant mutations include:

Precore mutations

May reduce or abolish HBeAg production.

Basal core promoter mutations

Can alter precore/core expression and are associated with HBeAg-negative disease.

Surface gene mutations

May:

• alter antigenicity

• contribute to immune escape

• interfere with diagnostic detection

• affect vaccine-induced antibody recognition in selected circumstances

Polymerase mutations

Can produce antiviral drug resistance.

42. Acute vs Chronic HBV Pathogenesis

43. The Central Paradox of HBV Immunopathogenesis

HBV produces an interesting biological paradox:

Strong immune response

→ more liver injury

but

→ better viral clearance.

Weak immune response

→ less acute hepatitis

but

→ greater probability of chronic infection.

Therefore:

This is the central concept of HBV pathogenesis.

44. Pathogenesis of Fulminant Hepatitis

Fulminant hepatitis B is uncommon.

It involves severe acute hepatocellular injury leading to:

• massive hepatic necrosis

• acute liver failure

• coagulopathy

• encephalopathy

An intense immune-mediated response is considered an important mechanism.

Factors influencing severe disease can include:

• host immune response

• viral factors

• coinfection/superinfection, particularly HDV

• age and underlying liver disease

45. Complete HBV Pathogenesis Flowchart

HBV exposure
      ↓
Entry into bloodstream
      ↓
Attachment to hepatocyte
      ↓
NTCP-mediated entry
      ↓
Nucleocapsid reaches nucleus
      ↓
rcDNA → cccDNA
      ↓
Viral transcription
      ↓
HBV protein synthesis
      ↓
Viral replication
      ↓
HBV antigen expression
      ↓
Innate + adaptive immune recognition
      ↓
 ┌─────────────────────────────┐
 │                             │
Strong immune response     Ineffective response
 │                             │
 ↓                             ↓
CTL activation             Viral persistence
 │                             ↓
 ↓                         cccDNA persistence
Hepatocyte injury              ↓
 │                         Chronic infection
 ↓                             ↓
Acute hepatitis            Chronic inflammation
 │                             ↓
 ↓                         Fibrosis
Viral clearance                ↓
 │                         Cirrhosis
 ↓                             ↓
Anti-HBs development       HCC risk

46. HCC Pathogenesis Flowchart

Persistent HBV infection
          ↓
      cccDNA
          ↓
Chronic inflammation
          ↓
Repeated hepatocyte injury
          ↓
Compensatory regeneration
          ↓
Oxidative stress + DNA damage
          ↓
Genetic/epigenetic alterations
          ↓
          ┌──────────────────────────┐
          │                          │
   HBV DNA integration           HBx activity
          │                          │
          ↓                          ↓
Genomic instability          Altered signaling
          │                          │
          └────────────┬─────────────┘
                       ↓
             Clonal hepatocyte
                expansion
                       ↓
             Dysplasia / premalignant
                  transformation
                       ↓
                    HCC

47. Key Molecular Mechanisms in HBV Pathogenesis

48. High-Yield Exam Pearls

Pearl 1

HBV is predominantly non-cytopathic.

Pearl 2

Most hepatocellular injury is due to the host immune response, especially HBV-specific T-cell responses.

Pearl 3

CD8+ CTLs are central to acute HBV liver injury and viral clearance.

Pearl 4

CTLs can suppress HBV replication without killing hepatocytes, through cytokines such as IFN-γ and TNF-α.

Pearl 5

cccDNA is the major persistent nuclear reservoir of HBV.

Pearl 6

Infection at birth/early infancy has a much greater probability of becoming chronic than infection in immunocompetent adults.

Pearl 7

HBeAg negativity does not necessarily mean absence of active HBV replication.

Pearl 8

Precore and basal core promoter mutations are important in HBeAg-negative HBV disease.

Pearl 9

Chronic HBV infection can progress:

Chronic hepatitis → fibrosis → cirrhosis → HCC

Pearl 10

HBV can cause HCC even without cirrhosis.

Pearl 11

HBV DNA integration is not required for replication but contributes to hepatocarcinogenesis.

Pearl 12

HBx is an important viral regulatory protein involved in HBV replication and carcinogenesis.

Pearl 13

Polyarteritis nodosa and certain glomerulopathies are classic extrahepatic manifestations of HBV.

Pearl 14

The immune response is simultaneously:

protective against HBV + responsible for much of the liver injury.

49. One-Minute Revision

HBV enters hepatocyte
        ↓
rcDNA → cccDNA
        ↓
Viral replication
        ↓
HBV antigen expression
        ↓
Immune recognition
        ↓
Strong HBV-specific T-cell response
        ↓
CTL-mediated liver injury
        +
Non-cytolytic viral suppression
        ↓
CLEARANCE

If immune control is inadequate:

Persistent HBV
     ↓
Persistent cccDNA
     ↓
Chronic infection
     ↓
Repeated inflammation
     ↓
Fibrosis
     ↓
Cirrhosis
     ↓
HCC

And HCC can also arise through:

HBV DNA integration
        +
HBx / viral protein effects
        +
Genomic instability
        +
Chronic regeneration
        +
Oxidative stress
        ↓
Hepatocarcinogenesis

50. Clinical Take-Home Message

HBV pathogenesis is fundamentally a virus-host interaction.

The virus establishes infection and persists through cccDNA, while the host immune system determines whether infection is cleared or becomes chronic.

A strong antiviral immune response can eliminate HBV but produces hepatocellular injury. An inadequate immune response may cause relatively little acute inflammation while allowing HBV to persist for decades.

Long-term disease results from the interaction of:

persistent virus + immune-mediated inflammation + fibrosis + viral oncogenic mechanisms + host cofactors.

The final consequences may therefore range from:

asymptomatic infection → acute hepatitis → chronic hepatitis → cirrhosis → hepatocellular carcinoma.

Standard References

1. Flint SJ, Enquist LW, Racaniello VR, Rall GF. Principles of Virology. ASM Press.

2. Knipe DM, Howley PM, editors. Fields Virology. Wolters Kluwer.

3. Bennett JE, Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Elsevier.

4. Murray PR, Rosenthal KS, Pfaller MA. Medical Microbiology. Elsevier.

5. Carroll KC, et al. Jawetz, Melnick & Adelberg's Medical Microbiology. McGraw-Hill.

6. Ryan KJ, Ray CG. Sherris Medical Microbiology. McGraw-Hill.

7. World Health Organization. Guidelines for the Prevention, Diagnosis, Care and Treatment for People with Chronic Hepatitis B Infection. WHO; 2024.

8. European Association for the Study of the Liver. EASL Clinical Practice Guidelines on the Management of Hepatitis B Virus Infection. 2025.

9. Terrault NA, et al. AASLD guidance on chronic hepatitis B.

10. Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nature Reviews Immunology.

11. Ganem D, Prince AM. Hepatitis B virus infection—natural history and clinical consequences. New England Journal of Medicine.

12. Bertoletti A, Ferrari C. Reviews on HBV-specific T-cell immunity and immune-mediated liver injury.

13. Maini MK, Burton AR. Reviews on T-cell responses and immune-mediated pathogenesis in chronic HBV infection.

Current guideline note: WHO's 2024 HBV guideline remains a key current global reference, while EASL published updated HBV clinical practice guidelines in May 2025.